Internship in Leukemia Research (Master Student) - JP0419

To be part of the Tumor Stroma Interactions research group (Head: PI: Dr. E. Moussay and Dr. Jérôme Paggetti) within the Department of Oncolgy at the LIH.
84, rue Val Fleuri, Luxembourg L-1526, Luxembourg
18/09/2019 15:42:00

Background: Chronic Lymphocytic Leukemia (CLL) represent the most frequent leukemia in adults. Despite recent advances in treatments, CLL remains a deadly uncurable disease. This cancer is caracterized by an accumulation of abnormal, apoptosis resistant, B lymphocytes in the blood and lymphoid organs of the patients. CLL progression is highly dependent on complex interactions between tumor cells and their microenvironment. Indeed, CLL cells can modify stromal cells and immune cells to promote their survival and to escape from the immune surveillance system.

Objectives: Our team focuses on the mechanisms leading to leukemia progression, in particular the influence of CLL cells on stromal cells and immune cells located in their microenvironment, with the goal to identify new prognostic markers and therapeutic targets.

Training and research environment: Tumor Stroma Interactions research group is a dynamic and multinational team whose current members originate from France, Belgium, Germany and Italy. It belongs to the Department of Oncology, whose research activities focus on the cellular and molecular mechanisms of tumor progression using a wide range of cutting edge technologies, including mass cytometry, transcriptomic and proteomic analyses, as well as in vitro and in vivo techniques using state-of-the art animal models for cancer research. Master students will assist one of our projects that aims to explore the interplay between leukemic cells and their microenvironment, and will be co-supervised by Dr. E. Moussay (PI), Dr. J. Paggetti (PI) and experienced scientists from the team.

Recent related reference (open access): Paggetti J, et al. Exosomes released by chronic lymphocytic leukemia cells induce cancer-associated fibroblast formation. Blood 126(9):1106-17.

Wierz M, et al. Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia. Blood 131(14):1617-1621. (IF:15.132)

What we offer and conditions:
  • Students will have the opportunity to work in an interactive and international scientific environment, attend conferences by eminent scientists from abroad, and present their own work during lab meetings.
  • They will receive training in basic biochemistry, molecular and cell biology techniques, such as Western-blotting, real-time PCR, and cell culture, as well as confocal imaging, flow cytometry and in vivo experiments on mouse models.
  • Mouse  experimentation practice and FELASA (or equivalent) diploma would be considered as an asset.
  • Applicants must be affiliated to their own University.
  • English is mandatory.
  • Master 2 students will receive 500 €/month unless they have their own funding source, e.g.Erasm,us grant.

REF.: VD/INTLEUK0419/JP/LECR TSI
Available for 6-12 months (can be adapted according to the specific requirements of the University - Full time

The applicants should submit a letter detailing their motivation and a curriculum vitae before 31 October 2019 via the apply" button" below.

Contacts

More information about the group can be found here : https://tsi.lih.lu

 Scientific contact
Dr. Jérôme PAGGETTI, PhD
84 Val Fleuri
L-1526 Luxembourg
LUXEMBOURG
Jerome.paggetti@lih.lu